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Figure 1. Phenolic profile of Origanum vulgare L. hydroalcoholic extract recorded at 
370 nm (A) and 280 nm (B). 
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Abstract 
Bioactivity of oregano methanolic extracts and essential oils is well known. 
Nonetheless, reports using aqueous extracts are scarce, mainly decoction or infusion 
preparations used for therapeutic applications. Herein, the antioxidant and antibacterial 
activities, and phenolic compounds of the infusion, decoction and hydroalcoholic 
extract of oregano were evaluated and compared. The antioxidant activity is related with 
phenolic compounds, mostly flavonoids, since decoction presented the highest 
concentration of flavonoids and total phenolic compounds, followed by infusion and 
hydroalcoholic extract. The samples were effective against gram-negative and gram-
positive bacteria. It is important to address that the hydroalcoholic extract showed the 
highest efficacy against Escherichia coli. This study demonstrates that the decoction 
could be used for antioxidant purposes, while the hydroalcoholic extract could be 
incorporated in formulations for antimicrobial features. Moreover, the use of 
infusion/decoction can avoid the toxic effects showed by oregano essential oil, widely 
reported for its antioxidant and antimicrobial properties. 
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1. Introduction 
Plants are used since ancient times by primitive societies due to therapeutic and 
psychotherapeutic benefits, among other healing properties. In recent years, it has been 
observed an increasing interest for biological properties of medicinal plants, in order to 
identify and evaluate their therapeutic potential, and also to identify the major bioactive 
compounds and possible synergisms (Bakkali, Averbeck, Averbeck, & Idaomar, 2008; 
Albano & Miguel, 2011).  
Origanum vulgare L. (oregano) is an herbaceous, perennial and very tough plant, 
belonging to the Lamiaceae (lipped) family. It is used, since ancient times, for 
medicinal purposes and, in particular, the antioxidant properties of O. vulgare 
methanolic extract (Economou, Oreopoulou, & Thomopoulos, 1991; Şahin et al., 2004; 
Koşar, Dorman, & Hiltunen, 2005; Škerget et al., 2005; Özbek et al., 2008; Barros, 
Heleno, Carvalho, & Ferreira, 2010; Kaurinovic, Popovic, Vlaisavljevic, & Trivic, 
2011; Spiridon, Bodirlau, & Teaca, 2011) and essential oils (Şahin et al., 2004; 
Alinkina, Misharina, & Fatkullina, 2012; Cekera et al., 2012; Quiroga et al., 2013) have 
been reported. Nevertheless, studies using aqueous extracts are scarce (Ličina et al., 
2013), especially in decoction or infusion preparations traditionally used due to 
digestive, expectorant, antiseptic and antispasmodic properties (Vanaclocha & 
Cañigueral, 2003). Some studies reported antibacterial activity of O. vulgare infusion 
and decoction (Chaudhry, Saeed, & Tariq, 2007; Saeed & Tariq, 2009), but using high 
concentrations (200 mg/mL and 100 mg/mL, respectively). In fact, the majority of 
reports regarding oregano antibacterial activity used essential oils (Vanaclocha & 
Cañigueral, 2003; Viuda-Martos, Ruiz-Navajas, Fernandez-Lopez, & Perez-Alvarez, 
2007; Bakkali et al., 2008; Rosato et al., 2009; Orhan, Özçelİk, Kartal, & Kan, 2012; 
Vale-Silva et al., 2012), which in some cases are toxic and non-tolerated by patients. In 
general, essential oils tend to have side effects, in different degrees, and for this reason 
they should never be used undiluted. Oregano essential oil is an example, and despite its 
wide variety of applications, it could be used both internally and topically, but its 
application should be used with same precaution, due to photosensitive, neurotoxic and 
hepatotoxic effects. The main compounds present in oregano essential oil are phenolic 
monoterpenes, carvacrol and thymol (Sivropoulou, 1996; Bakkali et al., 2008). Those 
substances, at therapeutic doses, are beneficial during a small period of time, but they 
can be toxic to liver, kidneys and nervous system if taken in excess. According to 
Tisserand & Balacs (1995), oregano essential oil is never topically applied to mucous 
membranes in concentrations higher than 1%, due to the possible irritating effect to the 
skin and even a possible burning effect. The same precaution should also be taken with 
individuals who have very sensitive or damaged skin, as well as with children less than 
two years of age, and during pregnancy, in which the oil application is not 
recommended (Tisserand & Balacs, 1995; Vanaclocha & Cañigueral, 2003; Longe, 
2005). The most important cases in which the use of oregano essential oil is not 
recommend include patients with gastritis, gastroduodenal ulcers, ulcerative colitis and 
other inflammatory bowel diseases, liver disease, epilepsy, Parkinson's disease or other 
neurological dysfunctions. Furthermore, oregano essential oil should be used with 
caution in cases of patients with epilepsy, due to their potential neurotoxic and 
convulsing effects. Despite the absence of clinical studies, there are a few reports on the 
side effects of oregano essential oil. Cleff et al. (2008), evaluated the toxicity of O. 
vulgare essential oil administered orally and with intravaginal applications during 30 
days, in adult females and Wistar rats, and concluded that 3% of the essential oil did not 
results in toxicological alterations. However, the authors recommend other studies 
namely, with different concentrations. Thus, oregano essential oil can be considered 
safe, when used correctly, never being taken internally, and topical applications should 
be performed after dilution, in a suitable carrier oil, and in low doses over a short period 
of time. 
Therefore, the identification and characterization of other bioactive molecules (e.g., 
phenolic compounds) beside essential oils is demanded, particularly in forms (decoction 
and infusion) traditionally used for therapeutic applications. The aim of this work was 
to assess antioxidant and antibacterial efficacy of decoction, infusion and 
hydroalcoholic extract of O. vulgare and to carry out identification of main beneficial 
compounds, in terms of phenolic composition. 
 
2. Materials and methods 
2.1. Sample 
Flowering aerial parts (leaves and flowers, separated from branches) of Origanum 
vulgare L., previously dried, supplied by Soria Natural (Garray - Soria, Spain), were 
obtained in September 2012. The sample was a clean product, with monitored 
parameters of pesticides, herbicides, heavy metals and radioactivity.  
 
2.2. Standards and reagents 
Methanol was of analytical grade purity and supplied by Pronalab (Lisbon, Portugal). 
2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained from Alfa Aesar (Ward Hill, MA, 
USA). HPLC-grade acetonitrile was obtained from Merck KgaA (Darmstadt, 
Germany). Formic and acetic acids were purchased from Prolabo (VWR International, 
France). The phenolic compound standards (apigenin 6-C-glucoside, chlorogenic acid, 
eriodictyol, kaempferol 3-O-glucoside, luteolin 7-O-glucoside, myricetin, 
protocatechuic acid, quercetin 3-O-glucoside, quercetin 3-O-rutinoside, rosmarinic acid, 
taxifolin) were from Extrasynthese (Genay, France). Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid) was purchased from Sigma Chemical Co. (St. 
Louis, MO, USA). Water was treated in a Milli-Q water purification system (TGI Pure 
Water Systems, Greenville, SC, USA). 
 
2.3. Preparation of the infusion, decoction and hydroalcoholic extract  
Hydroalcoholic extraction was performed using the plant material (1 g) stirring with 30 
mL of methanol:water (80:20, v/v) at 25 ºC and 150 rpm for 1 h, and filtered through 
Whatman No. 4 paper. The residue was then extracted with one additional 30 mL 
portion of the hydroalcoholic mixture. The combined extracts were evaporated at 35 ºC 
under reduced pressure (rotary evaporator Büchi R-210, Flawil, Switzerland) and then 
further lyophilized (FreeZone 4.5, Labconco, Kansas City, MO, USA). 
For infusion preparation, the sample (1 g) was added to 200 mL of boiling distilled 
water and left to stand at room temperature for 5 min, and then filtered under reduced 
pressure. For decoction preparation, the sample (1 g) was added to 200 mL of distilled 
water, heated (heating plate, VELP scientific) and boiled for 5 min. The mixture was 
left to stand for 5 min and then filtered under reduced pressure. The obtained infusions 
and decoctions were frozen and lyophilized. The lyophilized hydroalcoholic extract, 
was re-dissolved in methanol:water (80:20, v/v), while the infusion and decoction were 
re-dissolved in water, to obtain stock solutions of 20 mg/mL.  
 
2.4. Evaluation of bioactivity 
2.4.1. Antioxidant activity 
Four different in vitro assays were performed using serial dilutions of stock solution: 
scavenging effects on DPPH (2,2-diphenyl-1-picrylhydrazyl) radicals (RSA); reducing 
power (measured by ferricyanide Prussian blue assay) (RP); inhibition of β-carotene 
bleaching (CBI); and inhibition of lipid peroxidation in brain cell homogenates by 
TBARS (thiobarbituric acid reactive substances) assay (LPI). 
RSA was evaluated using an ELX800 microplate Reader (Bio-Tek Instruments, Inc; 
Winooski, VT, USA), and calculated as a percentage of DPPH discolouration through 
the formula: [(ADPPH-AS)/ADPPH] × 100, where AS is the absorbance of the solution 
containing the sample at 515 nm, and ADPPH is the absorbance of the DPPH solution.  
RP was evaluated by the capacity to convert Fe3+ into Fe2+, measuring the absorbance at 
690 nm in the microplate Reader mentioned above. CBI was evaluated though the β-
carotene/linoleate assay; the neutralization of linoleate free radicals avoids β-carotene 
bleaching, which is measured by the formula: β-carotene absorbance after 2h of 
assay/initial absorbance) × 100. LPI in pig (Sus scrofa) brain homogenates was 
evaluated by the decreasing in thiobarbituric acid reactive substances (TBARS); the 
colour intensity of the malondialdehyde-thiobarbituric acid (MDA-TBA) abduct was 
measured by its absorbance at 532 nm; the inhibition ratio (%) was calculated using the 
following formula: [(A - B)/A] × 100%, where A and B were the absorbance of the 
control and the sample solution, respectively. The results were expressed in EC50 
values, i.e. sample concentration providing 50% of antioxidant activity or 0.5 of 
absorbance in the reducing power assay (Barros et al., 2010).  
 
2.4.2. Antibacterial activity 
To evaluate antibacterial activity different bacteria strains from American Type Culture 
Collection (ATCC) were used, namely Gram positive species, Staphylococcus aureus 
(ATCC 25923) and Staphylococcus epidermidis (ATCC 35983), and Gram negative 
species, Escherichia coli (ATCC 25922), Klebsiella spp., Pseudomonas aeruginosa 
(ATCC 10145), Enterococcus aerogenes (ATCC 2048), Proteus vulgaris (ATCC 6380) 
and Enterobacter sakazakii (ATCC 29544). The antibacterial effect was evaluated using 
the disc diffusion halo test (NCCLS/CLSI & ANVISA, 2003). For that, each species 
was cultivated in a liquid medium, containing 30 mL of Tryptic Soy Broth (TSB), 
during 24h. After that, the concentration of each species was normalized for 0.5 of 
optical density (with approximately 1x107 cells/mL) by absorbance determination at 
600 nm. An aliquot of each species (300 µL) was spread in Tryptic Soy Agar (TSA) 
petri dishes. Then, an aliquot of 25 µL of each sample (decoction, infusion and 
hydroalcoholic extract- 20 mg/mL), was placed on sterile blank disc. Sterile water was 
used as negative control. The plates were incubated at 37 ºC, during 24-48h. 
Antibacterial activity was measured using a qualitative method, based on disc diffusion 
assay. In this study, the qualitative results were converted in a semi-quantitative scale 
being classified the distinctness of the halo as: (-) absence of halo; (+) weak halo; (++) 
moderate halo; (+++) strong halo. Absence of halo concerning to 0.0 mm; weak halo 
between 0.3-0.7 mm; moderate halo 8-1.0 mm, and strong halo greater than 1.1 mm. 
 
2.5. Analysis of phenolic compounds  
Phenolic compounds were determined by HPLC (Hewlett-Packard 1100, Agilent 
Technologies, Santa Clara, CA, USA) as previously described by Barros et al. (2013a). 
Double online detection was carried out in the diode array detector (DAD) using 280 
nm and 370 nm as preferred wavelengths and in a mass spectrometer (MS) connected to 
the HPLC system via the DAD cell outlet. The phenolic compounds present in the 
samples were characterised according to their UV and mass spectra and retention times 
compared with commercial standards when available. The phenolic compounds were 
identified by comparing their retention time, UV–vis and mass spectra with those 
obtained from standard solutions, when available. Otherwise, peaks were tentatively 
identified comparing the obtained information with available data reported in the 
literature. For quantitative analysis, a calibration curve (1-100 µg/mL) for each 
available phenolic standard was constructed based on the UV signal: apigenin-6-C-
glucoside (y=517.4x+268.26; R2=0.9921); chlorogenic acid (y=313.03x-58.2; 
R2=0.999); kaempferol 3-O-glucoside (y=288.55x-4.0503; R2=1); kaempferol 3-O-
rutinoside (y=239.16x-10.587; R2=1); luteolin 7-O-glucoside (y=80.829x-21.291; 
R2=0.999); myricetin (y=741.41x-221.6; R2=0.999); protocatechuic acid (y=291.1x-
6.4558; R2=0.999); quercetin 3-O-glucoside (y=363.45x+117.86; R2=0.9994), quercetin 
3-O-rutinoside (y=281.98x-0.3459; R2=1); rosmarinic acid (y=336.03x+170.39; 
R2=0.999) and taxifolin (y=478.06x +657.33; R2=0.999). For the identified phenolic 
compounds for which a commercial standard was not available, the quantification was 
performed through the calibration curve of other compound from the same phenolic 
group. The results were expressed in mg per g of extract. 
 
2.6. Statistical analysis.  
All the samples of oregano (infusion, decoction and hydroalcoholic extract) were 
prepared and analyzed in triplicate. The results, expressed as mean values and standard 
deviation (SD), were analyzed using one-way analysis of variance (ANOVA) followed 
by Turkey’s HSD Test with α = 0.05, performed with SPSS (Statistical Package for the 
Social Sciences) v. 22.0 program (IBM). 
 
3. Results and Discussion 
3.1. Evaluation of antioxidant activity 
The antioxidant properties were evaluated by determining reducing power (RP), free 
radicals scavenging activity (RSA), β-carotene bleaching inhibition (CBI) and lipid 
peroxidation inhibition (LPI) in brain cell homogenates. The results are shown in Table 
1. The infusion and decoction samples presented similar RP and RSA, but the decoction 
gave higher CBI and LPI than the infusion. Both preparations (infusion and decoction) 
gave, in all the performed assays, higher antioxidant activity than the hydroalcoholic 
extract. Therefore, the compounds with stronger antioxidant activity in oregano seem to 
be water-soluble.  
It should be highlighted that infusions can be used in a wide range of medical conditions 
by the majority of people without causing any adverse/toxic effect, not only by internal 
but also by external use (EFSA, 2010). Nevertheless, European Commission and other 
health organizations consider that due to the lack of an adequate dossier, the safety of 
oregano and other medicinal plants cannot be assessed (EFSA, 2010). Thus, their use 
for medicinal purposes should be avoided in the absence of therapeutic indications. 
However, it should be noted that the use of oregano as spice, herbal food ingredient and 
in folk medicine has a safe history, being cited since ancient times (Longe, 2005; 
Vanaclocha & Cañigueral, 2003). In fact, due to the extensive culinary use, oregano is 
listed as Generally Recognised As Safe (GRAS), in the Code of Federal Regulations 
(http://www.ecfr.gov/cgi-bin/ECFR) and had never been restricted by any worldwide 
authority. European Food and Safety Authority (EFSA) reports a high antioxidant 
efficacy of oregano as food additive, but without a dossier supporting its use and 
reporting safety levels (EFSA, 2010).  
Alinkina et al. (2012) described a higher antioxidant activity of oregano essential oils 
compared to individual phenols (thymol and carvacrol), which means that other 
important compounds have interactions and establish a synergic effect. Similar results 
were shown by Quiroga et al. (2013), comparing the chemical composition, antioxidant 
and anti-lipase activities of O. vulgare and Lippia turbinate essential oils. The authors 
concluded that, despite the similarity in the antioxidant activity of both essential oils, 
oregano showed higher anti-lipase and scavenging activities than Lippia, attributing 
those properties to its higher phenolic content. Şahin et al. (2004) also described strong 
free radicals scavenging properties of oregano methanolic extract (due to phenolic 
content), but a weaker activity of its essential oils. They also observed that a methanolic 
extract did not effectively inhibited linoleic acid oxidation (Şahin et al., 2004). This 
should be in agreement with our study, in which the hydroalcoholic extract showed 
lower inhibitory activity of β-carotene bleaching (CBI EC50 371.45±12.40 µg/mL) than 
radical scavenging activity (RSA value 246.45±24.00 µg/mL). 
Other authors, reporting the antioxidant activity of some plant extracts of the family 
Lamiaceae, including oregano, attributed their scavenging activity to phenolic and 
flavonoid contents (Economou et al., 1991; Škerget et al., 2005; Kaurinovic et al., 2011; 
Spiridon et al., 2011). Furthermore, Kaurinovic et al. (2011) also described strong 
antioxidant effects for oregano aqueous extracts in comparison with organic extracts, 
which is in accordance with our experiment where decoction and infusion gave higher 
antioxidant activity than the hydroalcoholic extract. The antioxidant activity reported by 
Barros et al. (2010) for a methanolic extract obtained from wild oregano was, in 
general, higher than the one shown by hydroalcoholic extract, but lower than 
antioxidant properties of infusion/decoction. 
 
3.2. Evaluation of antibacterial activity 
The results obtained in the screening of antibacterial activity by disc diffusion halo 
assay are present in Table 2. The results revealed that the samples were, in general, 
effective against the gram-negative and gram-positive bacteria tested, despite the most 
pronounced effect was observed against the gram-negative bacteria, specifically E. coli 
and P. aeruginosa. It was very interesting to observe the variability among the different 
species of the same genus tested, namely Enterobacter spp. and Staphilococcus spp, 
gram-negative and gram-positive bacteria, respectively. In fact, the effect was opposite 
in the two species of each genus.  
Decoction and infusion had similar potential against almost all the tested bacteria, 
whereas the hydroalcoholic extract showed relatively higher efficacy against some 
strains (namely, E. coli and P. vulgaris) than the former. Chaudhry et al. (2007), using 
an essential oil, infusion and decoction of oregano, reported inhibitory effects against 
gram-negative bacteria (Aeromonas hydrophila, Citrobacter spp., E. aerogenes, E. coli, 
Flavobacterium spp., Klebsiella ozaenae, Klebsiella pneumoniae, P. mirabilis, P. 
aeruginosa, Salmonella typhi, S. paratyphi B, Serratia marcescens and Shigella 
dysenteriae). The highest inhibitory activity was obtained using essential oil against 
Citrobacter spp., whereas infusion showed inhibitory activity against all type of bacteria 
strains, namely Klebsiella pneumonia, Klebsiella ozaenae and Enterobacter aerogenes. 
All the bacteria showed resistance to oregano decoction. Despite in our experiment no 
antibacterial activity has been detected against Klebsiella spp., it should be highlighted 
that the concentration used (20 mg/mL) was considerably lower than the tested by those 
authors (200 mg/mL) (Chaudhry et al., 2007). Moreover, the results obtained under this 
study showed antibacterial activity by the decoction (20 mg/mL) against E. aerogenes, 
E. coli and P. aeruginosa. Saeed & Tariq (2009) found that the infusion was more 
effective than the essential oil of oregano against gram-positive bacteria 
(Staphylococcus saprophyticus, S. aureus, Micrococcus roseus, M. kristinae, M. 
nishinomiyaensis, M. lyla, M. luteus, M. sedentarius, M. varians, Bacillus megaterium, 
B. thuringiensis, B. alvei, B. circulans, B. brevis, B. coagulans, B. pumilus, B. 
laterosporus, B. polymyxa, B. macerans, B. subtilis, B. firmus, B. cereus and B. 
lichiniformis) whereas no antibacterial activity was found using oregano decoction (100 
mg/mL).  
 
3.3. Analysis of phenolic compounds  
The phenolic profile of O. vulgare, obtained after hydroalcoholic extraction, and 
recorded at 370 nm is shown in Figure 1; peak characteristics and tentative identities 
are presented in Table 3. Twenty two compounds were detected, six of which were 
phenolic acid derivatives and sixteen flavonoids. Protocatechuic (peak 2), 5-O-
caffeoylquinic (peak 3) and rosmarinic acid (peak 15) were positively identified 
according to their retention, mass and UV-vis characteristics by comparison with 
commercial standards. Peak 1 ([M-H]- at m/z 353) was identified as 3-O-caffeoylquinic 
acid, yielding the base peak at m/z 191 and the ion at m/z 179 with an intensity >66% 
base peak, characteristic of 3-acylchlorogenic acids as reported by Clifford, Johnston, 
Knight, & Kuhnert (2003) and Clifford, Knight, & Kuhnert, 2005). Peak 8 presented a 
pseudo molecular ion [M-H]- at m/z 421, yielding a unique fragment ion at m/z 153. 
Nakatani & Kikuzaki (1987) identified a compound with the same molecular weight in 
O. vulgare as 4-(3,4-dihydroxybenzoyloxymethyl)phenyl-β-D-glucopyranoside and 
recently, Zhang et al. (2014) also identified and isolated a similar compound in O. 
vulgare, with the same molecular weight and UV spectra, as 4-[[(2’,5’-
dihydroxybenzoyl)oxy]methyl]phenyl O-β-D-glucopyranoside. A compound with the 
same mass and UV characteristics was also identified by Miron et al. (2011) as 
protocatechuic acid hexoside, although such a structure should be wrong as it does not 
match with its molecular ion and no discussion is made in the paper about the reasons 
for giving that identity. Furthermore, it would not be logical a hexoside elute later than 
the parent phenolic acid. Thus, the peak could be assigned as 4-[[(2’,5’-
dihydroxybenzoyl)oxy]methyl]phenyl O-β-D-glucopyranoside, due to its similar UV 
and MS spectra. 
Peak 19 presented a pseudo molecular ion [M-H]- at m/z 537 and a UV spectrum and 
fragmentation pattern consistent with the caffeic acid trimer lithospermic acid A. This 
compound can easily lose 8"-carboxyl group (-44 mu) releasing a fragment at m/z 493 
that further breaks down to form the fragment ions at m/z 313 and 295 (Barros et al., 
2013b). Salvianolic acids H/I, with the same molecular weight as lithospermic acid A, 
were discarded as possible identities because they present quite a different 
fragmentation pattern (Ruan, Li, Li, Luo, & Kong, 2012).  
Myricetin 3-O-glucoside (peak 6), taxifolin (peak 9), quercetin 3-O-rutinoside (peak 
10), luteolin 7-O-glucoside (peak 13), eridictyol (peak 20) and naringenin (peak 22) 
were positively identified according to their retention, mass and UV-vis characteristics 
by comparison with commercial standards.  
Peak 12 presented a UV spectrum characteristic of luteolin (λmax at 350 nm) and a 
pseudo molecular ion [M-H]- at m/z 461, releasing fragments at m/z 285 ([M-176]-, loss 
of a glucuronyl moiety), being identified as luteolin O-glucuronide. Peaks 4, 14 and 16 
were identified as apigenin derivatives according to their UV and mass spectra 
characteristics. Peak 4 presented a pseudo molecular ion [M-H]- at m/z 593, releasing 
three MS2 fragment ions at m/z 473 and 383, corresponding to the loss of 120 and 90 mu 
characteristic of C-hexosyl flavones, and at m/z 353 that would correspond to the 
apigenin aglycone bearing some sugar residues [apigenin + 83 mu] (Ferreres, Silva, 
Andrade, Seabra, & Ferreira, 2003). The fact that no relevant fragment derived from the 
loss of a complete hexosyl residue (-162 mu) was detected suggested that both sugars 
were C-attached, which allowed a tentative identification of the compound as apigenin 
C-hexoside C-hexoside. This compound can be identified as apigenin 6,8-di-C-
glucoside (vicenin-2) previously identified in Origanum vulgare by Grevsen, Fretté, & 
Christensen (2009) and Koukoulitse et al. (2006); and has also been described to be a 
normal constituent of O. vulgare. Peaks 14 and 16 showed pseudo molecular ions [M-
H]- at m/z 577 and 445, respectively, both releasing an MS2 fragment at m/z 269 ([M-
308]- and [M-176]-, respective losses of rutinosyl and glucuronyl moieties). These 
compounds were tentatively assigned as apigenin 7-O-rutinoside and apigenin 7-O-
glucuronide as they were previously identified in oregano by Hossain, Rai, Brunton, 
Martin-Diana, & Barry-Ryan (2010) and Grevsen et al. (2009). 
Peak 21 showed a pseudo molecular ion [M-H]- at m/z 459, releasing two MS2 
fragments at 283 ([M-176]-, loss of a glucuronyl moiety) and 268 (apigenin, further loss 
of a methyl residue), being tentatively assigned as methylapigenin O-glucuronide. The 
presence of acacetin (4’-O-methylapigenin) and another methylapigenin in oregano was 
reported by Hossain et al. (2010).  
Pseudo molecular ([M-H]- at m/z 463) and product (m/z at 301, quercetin) ions of peaks 
7 and 11 allowed their identification as quercetin O-hexosides. Peak 11 showed λmax at 
higher wavelength (368 nm) than quercetin 3-O-glucoside (344 nm) and similar to 
quercetin aglycone. According to Mabry, Markham, & Thomas (1970), the introduction 
of a glycoside on the hydroxyls at positions 7, 3’ or 4’ should not have effect on 
maximal wavelength or the spectrum shape in relation to the aglycone. Thus, peak 11 
was tentatively assigned as quercetin 7-O-hexoside. An undefined quercetin 3-O-
hexoside was also reported to occur in oregano by Hossain et al. (2010).  
Peaks 5 and 17 were identified as kaempferol derivatives, according to their UV and 
mass spectra characteristics. Peak 5 showed a pseudo molecular ion [M-H]- at m/z 609, 
releasing two MS2 fragments at m/z 447 ([M-H-162]-, loss of a hexosyl moiety) and 285 
(kaempferol; [M-H-162-162]-, loss of a further hexosyl moiety), being identified as 
kaempferol O-hexosyl-O-hexoside. Peak 17 presented a pseudo molecular ion at m/z 
447 and a MS2 fragment at m/z 285 (kaempferol; [M-H-162-162]-, loss of a further 
hexosyl moiety), being identified as kaempferol O-hexoside. Peak 18 presented a 
pseudo molecular ion [M-H]- at m/z 475, yielding fragment ions at m/z 299 and 284, 
associated to the loss of a glucuronyl moiety (176 mu) and a further -CH3 group (15 
mu), which allowed its tentative identification as kaempferide O-glucuronide.  
From the 22 compounds identified, six were phenolic acids being rosmarinic acid the 
most abundant in all the preparations. The remaining compounds were flavonoid 
derivatives, being luteolin 7-O-glucoside (hydroalcoholic acid) and luteolin O-
glucuronide (infusion and decoction) the most abundant compounds found. Decoction 
presented the highest concentration of flavonoids (75.25 mg/g decoction) and total 
phenolic compounds (98.05 mg/g decoction), followed by infusion and hydroalcoholic 
extract, respectively. This is also in agreement with the results obtained for antioxidant 
activity, where decoction presented the highest activity. The concentration of phenolic 
acids did not present significant variation between the three different preparations.  
There are several publications reporting the phenolic composition of O. vulgare from 
different origins and using different extraction methodologies. Nevertheless, none of 
those samples exhibited the same phenolic profile, presenting only few similarities in 
some of the compounds identified (Rodríguez-Meizoso et al., 2006; Skoula, Grayer, 
Kite, & Veitch, 2008; Grevsen et al., 2009; Hossain et al., 2010; Shen et al., 2010; 
Miron, Plaza, Bahrim, Ibáñez, & Herrero, 2011; Agiomyrgianaki & Dais, 2012). Miron 
et al. (2011) presented the phenolic composition of O. vulgare from Romania after 
pressurized liquid extraction with water and ethanol. Those authors identified twelve 
compounds: eight phenolic acids namely, syringic acid, protocatechuic acid, 
protocatechuic glucoside, homovanillic acid, hydroxybenzoic acid, caffeic acid, 
rosmarinic acid and caffeic acid ethyl ester; and four flavonoids namely, luteolin 7-O-
glucuronide, apigenin, luteolin, and naringenin. That study did not present any 
quantification, however, by the chromatographic profile showed in the paper, 
rosmarinic acid seemed to be the most abundant compound. Rodríguez-Meizoso et al. 
(2006) studied dried oregano leaves from Spain, using subcritical water extraction, but 
these authors did not present any quantification nor identification of the phenolic 
compounds, only proposing the chemical family for some compounds (flavanones, 
dihydroflavonols, flavonols and flavones). Agiomyrgianaki & Dais (2012) analysed a 
sample of O. vulgare from Greece, using ethanol and ethyl acetate as extraction 
solvents. These authors identified and quantified nine phenolic compounds namely, 
ferulic acid, apigenin, oleanolic acid, ursolic acid, rosmarinic acid, chlorogenic acid, 
naringenin, eriodictyol and taxifolin. Shen et al. (2010) only described the presence of 
rosmarinic, oleanolic and ursolic acids in samples of O. vulgare from Greece and in 
another unspecific sample from Europe. Rosmarinic acid was the most abundant 
compound found in all the studied samples. 
Skoula et al. (2008) reported the presence of fourteen phenolic compounds in a sample 
from Greece, extracted with ethanol. That study presented a variety of different phenolic 
compounds that were not identified in the other studies mentioned above, and also from 
the ones identified herein. The authors presented four similar phenolic compounds 
namely apigenin, naringenin, eriodictyol and taxifolin.  
Moreover, Hossain et al. (2010) reported the presence of thirty four phenolic 
compounds (fourteen phenolic acids, fifteen flavonoids and five other phenolic 
compounds) in a sample from Ireland, extracted with aqueous methanol (80%), using a 
homogenizer and shaken overnight. The phenolic compounds identified in this study 
presented similarities to the identifications performed by Hossain et al. (2010), but some 
differences were observed, especially regarding phenolic acids. Grevsen et al. (2009) 
identified nineteen phenolic compounds (five phenolic acids and fourteen flavonoids) in 
a sample of O. vulgare ssp. Hirtum (Greek oregano) cultivated in cool temperature 
climate in Denmark. They performed a similar extraction procedure as Hossain et al. 
(2010) and the compounds identified were slightly similar to the ones found in this 
study. 
 
Overall, there is diversity in the characterization of the phenolic compounds of samples 
from different countries and using different extraction procedures. Nevertheless, the 
infusion and decoction of O. vulgare were never characterized nor quantified, until now.  
Both preparations, mostly decoction, gave higher antioxidant activity than the 
hydroalcoholic extract. The antioxidant properties seem to be related to phenolic 
compounds, mainly flavonoids, since decoction presented the highest concentration of 
flavonoids and total phenolic compounds, followed by infusion and hydroalcoholic 
extract, respectively. Phenolic acids content (found in lower amounts in comparison 
with flavonoids) did not varied among different samples. Rosmarinic acid was the most 
abundant phenolic acid in all the preparations, while luteolin 7-O-glucoside 
(hydroalcoholic acid) and luteolin O-glucuronide (infusion and decoction) were the 
most abundant flavonoids. Furthermore, all the samples were effective against gram-
negative and gram-positive bacteria, but the most pronounced effect was observed 
against the gram-negative bacteria, E. coli and P. aeruginosa. The hydroalcoholic 
extract showed a higher efficacy against some species namely, E. coli and P. vulgaris, 
while decoction and infusion had similar antimicrobial potential.  
This study confirms the bioactive potential of oregano besides its use as food 
condiment; the decoction could be used for antioxidant purposes, while the 
hydroalcoholic extract could be incorporated in formulations for antimicrobial features. 
Moreover, the use of infusion/decoction, by internal or external use, can avoid the toxic 
effects showed by other oregano fractions such as essential oil. Further studies should 
be performed in order to establish in vivo bioactive properties.  
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Table 1. Antioxidant activity (EC50 values, µg/mL) of infusion, decoction and 
hydroalcoholic extract of Origanum vulgare L. (mean ± SD). 
EC50 values correspond to the sample concentration providing 50% of antioxidant 
activity or 0.5 of absorbance in the reducing power assay. Higher EC50 values 
correspond to lower antioxidant activity. 
 Infusion Decoction Hydroalcoholic extract 
DPPH scavenging activity (RSA)  142.43±10.30a 132.93±6.61a 246.45±24.00b 
Reducing power (RP) 116.26±0.45a 111.06±8.16a 237.45±8.51b 
β-carotene bleaching inhibition (CBI)  262.30±2.58b 115.69±16.34c 371.45±12.40a 
TBARS inhibition (LPI) 22.75±0.54b 8.73±0.55c 33.66±2.93a 
 Table 3. Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, identification and 
quantification of phenolic compounds in hydroalcoholic extract, infusion and decoction of Origanum vulgare L. 
Peak 
Rt  
(min) 
λmax 
 (nm) 
Molecular ion  
[M-H]- (m/z) 
MS2 
(m/z) 
Identification 
Quantification (mg/g extract) 
Hydroalcoholic   Infusion Decoction 
1 5.79 328 353 191(100),179(66),173(4),135(45) 3-O-Caffeolyquinic acid 0.37 ± 0.07 0.64 ± 0.01  0.55 ± 0.07 
2 6.31 260,sh294 153 123(8),109(100) Protocatechuic acid 0.63 ± 0.06 1.07 ± 0.05 1.02 ± 0.06 
3 8.67 328 353 191(100),179(4),173(2),161(4),135(2) 5-O-Caffeolyquinic acid 0.92 ± 0.04 0.96 ± 0.01 0.81 ± 0.03 
4 11.75 330 593 473(16),383(10),353(16),297(2) Apigenin 6,8-di-C-glucoside  0.52 ± 0.06 0.92 ± 0.00 0.98 ± 0.00 
5 15.46 340 609 447(100),285(12) Kaempferol O-hexosyl-O-hexoside 0.15 ± 0.01 0.22 ± 0.01 0.21 ± 0.01 
6 17.12 360 479 317(100) Myricetin 3-O-glucoside 0.58 ± 0.01 0.52 ± 0.00 0.58 ± 0.00 
7 18.01 344 463 301(100) Quercetin O-hexoside 0.41 ± 0.03 0.61 ± 0.02 0.57 ± 0.03 
8 18.58 264,sh290 421 153(100) 
4-[[(2’,5’ Dihydroxybenzoyl)oxy]methyl]phenyl 
O-β-D-glucopyranoside 
3.46 ± 0.05 2.11 ± 0.16 2.54 ± 0.22 
9 19.31 290 303 285(80), 125(100) Taxifolin 0.47 ± 0.02 0.31 ± 0.05 0.38 ± 0.38 
10 19.91 354 609 301(100) Quercetin 3-O-rutinoside  3.71 ± 0.01 2.88 ± 0.02 3.16 ± 0.07 
11 20.80 368 463 301(100) Quercetin 7-O-hexoside 0.54 ± 0.07 nd nd 
12 21.12 350 461 285(100) Luteolin O-glucuronide 12.48 ± 0.09 26.50 ± 0.15 28.27 ± 0.24 
13 21.32 348 447 285(100) Luteolin 7-O-glucoside 20.88 ± 0.00 22.93 ± 0.83 25.26 ± 0.44 
14 24.12 332 577 269(100) Apigenin 7-O-rutinoside 1.53 ± 0.06 0.74 ± 0.00 1.09 ± 0.07 
15 24.71 330 359 197(49),179(45),161(100),135(21) Rosmarinic acid 14.62 ± 0.03 15.91 ± 0.34 15.42 ± 0.15 
16 25.87 338 445 269(100) Apigenin 7-O-glucuronide 5.78 ± 0.03 8.24 ± 0.48 8.63 ± 0.02 
17 26.37 340 447 285(100) Kaempferol O-hexoside 1.30 ± 0.03 0.67 ± 0.21 0.76 ± 0.06 
18 28.25 354 475 299(100),284(47) Kaempferide O-glucuronide  1.58 ± 0.11 3.99 ± 0.03 3.97 ± 0.02 
19 28.46 328 537 
493(100),359(88),313(10),295(53),197
(16),179(35),161(73),135(50) 
Lithospermic acid A 2.33 ± 0.10 2.20 ± 0.05 2.45 ± 0.16 
20 31.02 288 287 151(90),135(100) Eridictyol 0.85 ± 0.01 0.22 ± 0.05 0.30 ± 0.08 
21 35.01 342 459 283(100),269(12) Methylapigenin O-glucuronide 1.26 ± 0.13 0.61 ± 0.02 0.79 ± 0.01 
22 36.94 288,sh334 271 151(90),119(73) Naringenin  0.43 ± 0.04 0.17 ± 0.03 0.29 ± 0.01 
     Phenolic acids 22.33 ± 0.07
a 22.89 ± 0.39a 22.80 ± 0.62a 
     Flavonoids 52.47 ± 0.18
c 69.52 ± 0.74b 75.25 ± 0.54a 
     Total phenolic compounds 74.79 ± 0.11
c 92.40 ± 0.35b 98.05 ± 1.16a 
 Table 2. Antibacterial activity of infusion, decoction and hydroalcoholic extract of 
Origanum vulgare L. against several bacterial species  
 (-) absence of halo; (+) weak halo; (++) moderate halo; (+++) strong halo 
 
Antibacterial activity 
Infusion 
(20 mg/mL) 
Decoction 
(20 mg/mL) 
Hydroalcoholic 
extract  (20 mg/mL) 
Gram 
positive 
Staphylococcus aureus - - - 
Staphylococcus epidermidis + + + 
Gram 
negative 
Escherichia coli ++ + +++ 
Klebsiella spp. - - - 
Pseudomonas aeruginosa + ++ ++ 
Enterobacter aerogenes - + - 
Enterobacter sakazakii + + + 
Proteus vulgaris + + ++ 
